Gene · 1457
Papers3,014
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,014
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phosphoproteomics guides low dose drug combination of cisplatin and silmitasertib against concurrent chemoradiation resistant cervical cancer. | Mol Omics | 2025 | 39665434 | PubTator, text mining | PubMed |
| Oncogenic cholesterol rewires lipid metabolism in hepatocellular carcinoma via the CSNK2A1-IGF2R Ser2484 axis. | J Adv Res | 2025 | 39547439 | PubTator, text mining | PubMed |
| Expanding the phenotypic spectrum of CSNK2A1-associated Okur-Chung neurodevelopmental syndrome. | HGG Adv | 2025 | 39497417 | PubTator, text mining | PubMed |
| Missense mutation in the activation segment of the kinase CK2 models Okur-Chung neurodevelopmental disorder and alters the hippocampal glutamatergic synapse. | Mol Psychiatry | 2025 | 39367055 | PubTator, text mining | PubMed |
| Transcriptomic Analysis of HPV-Positive Oesophageal Tissue Reveals Upregulation of Genes Linked to Cell Cycle and DNA Replication. | Int J Mol Sci | 2024 | 39795915 | PubTator, text mining | PubMed |
| REGγ is essential to maintain bone homeostasis by degrading TRAF6, preventing osteoporosis. | Proc Natl Acad Sci U S A | 2024 | 39536082 | PubTator, text mining | PubMed |
| A guide to selecting high-performing antibodies for CSNK2A1 (UniProt ID: P68400) for use in western blot, immunoprecipitation and immunofluorescence. | F1000Res | 2024 | 39403680 | PubTator, text mining | PubMed |
| Identification of novel proteins for coronary artery disease by integrating GWAS data and human plasma proteomes. | Heliyon | 2024 | 39386869 | PubTator, text mining | PubMed |
| Phosphorylation mapping of laminin γ1-chain: Kinases, functional interaction sequences, and phosphorylationinterfering cancer mutations. | J Biosci | 2024 | 39311033 | PubTator, text mining | PubMed |
| Comprehensive landscape of gastric cancer-targeted therapy and identification of CSNK2A1 as a potential target. | Heliyon | 2024 | 39253198 | PubTator, text mining | PubMed |
| Proteogenomic network analysis reveals dysregulated mechanisms and potential mediators in Parkinson's disease. | Nat Commun | 2024 | 39080267 | PubTator, text mining | PubMed |
| Patient organization perspective: a research roadmap for Okur-Chung Neurodevelopmental Syndrome. | Ther Adv Rare Dis | 2024 | 39070093 | PubTator, text mining | PubMed |
| Diversity of post-translational modifications and cell signaling revealed by single cell and single organelle mass spectrometry. | Commun Biol | 2024 | 39030393 | PubTator, text mining | PubMed |
| Subtelomeric microdeletion in chromosome 20p13 associated with short stature. | Clin Case Rep | 2024 | 38863865 | PubTator, text mining | PubMed |
| Inherited loss of function variant in CSNK2A1: the oldest reported cases of Okur-Chung syndrome in a single family. | Clin Dysmorphol | 2024 | 38818820 | PubTator, text mining | PubMed |
| Gene signatures of endoplasmic reticulum stress and mitophagy for prognostic risk prediction in lung adenocarcinoma. | IET Syst Biol | 2024 | 38813617 | PubTator, text mining | PubMed |
| Patient with a heterozygous pathogenic variant in CSNK2A1 gene: A new case to update the Okur-Chung neurodevelopmental syndrome. | Am J Med Genet A | 2024 | 38711237 | PubTator, text mining | PubMed |
| Multi-omics characterization of esophageal squamous cell carcinoma identifies molecular subtypes and therapeutic targets. | JCI Insight | 2024 | 38652547 | PubTator, text mining | PubMed |
| Modulating the Activity of the Human Organic Cation Transporter 2 Emerges as a Potential Strategy to Mitigate Unwanted Toxicities Associated with Cisplatin Chemotherapy. | Int J Mol Sci | 2024 | 38474165 | PubTator, text mining | PubMed |
| Okur-Chung neurodevelopmental syndrome: Implications for phenotype and genotype expansion. | Mol Genet Genomic Med | 2024 | 38444259 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1457/papers?page=4